A New Senolytic Enters Human Trials | Lifespan News

Lifespan News is moving to X10's new channel! https://www.youtube.com/lifextenshow

▼▼ Description, sources, and more below ▼▼

In this episode of Lifespan News:

0:00 Intro
0:37 Regenerating Skin With a Single Protein
1:27 A New Senolytic Enters Human Trials
2:27 T Cell Progenitors Boost Stem Cell Therapy Effectiveness
4:24 Creating Anti-Glucosepane Antibodies
5:41 Big pharma enters senolytic drug discovery program

Visit https://youtube.com/BrentNally for more of Brent's content!

Executive Producer: Keith Comito
Producer: Nicola Bagalà
Assistant Producer: Sedeer el-Showk
Video Editors: Tim Maupin, Brent Nally
Text Editor: Josh Conway

SOURCES AND FURTHER READING
⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺
Regenerating Skin With a Single Protein:
https://www.lifespan.io/news/regenerating-skin-with-a-single-protein/
https://scitechdaily.com/genetic-factor-discovery-enables-adult-skin-to-regenerate-like-a-newborn-babys/
https://skinregeneration.org/

A New Senolytic Enters Human Trials:
https://www.lifespan.io/news/a-new-senolytic-enters-human-trials/

T Cell Progenitors Boost Stem Cell Therapy Effectiveness:
https://www.lifespan.io/news/t-cell-progenitors-boost-stem-cell-therapy-effectiveness/

Creating Anti-Glucosepane Antibodies:
https://www.lifespan.io/news/creating-anti-glucosepane-antibodies/

Big pharma enters senolytic drug discovery program:
https://www.longevity.technology/big-pharma-enters-senolytic-drug-discovery-programme/

HOW YOU CAN SUPPORT US
⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺
If you’d like to help us run this show and/or help Lifespan.io end age-related diseases, you can become a Lifespan Hero: https://lifespan.io/hero. Your support means the world to us!

FOLLOW US EVERYWHERE
⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺
Website: https://lifespan.io/lifextenshow
Instagram: https://instagram.com/lifespanio
Facebook: https://facebok.com/lifespanio
Twitter: https://twitter.com/lifespanio
Discord: https://discord.gg/HwTX7gR

⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺
#Skin #Type2Diabetes #SenescentCells #ClinicalTrials #Cancer #ImmuneSystem #Glucosepane #AI #Insilico

Видео A New Senolytic Enters Human Trials | Lifespan News канала Life Extension Advocacy Foundation